Suppr超能文献

使用钙增敏剂左西孟旦治疗严重钙通道阻滞剂过量。

Treatment of serious calcium channel blocker overdose with levosimendan, a calcium sensitizer.

作者信息

Varpula Tero, Rapola Janne, Sallisalmi Marko, Kurola Jouni

机构信息

Department of Anesthesiology and Intensive Care Medicine, Jorvi Hospital, Turuntie 150, 02740 Espoo, Finland.

出版信息

Anesth Analg. 2009 Mar;108(3):790-2. doi: 10.1213/ane.0b013e3181931737.

Abstract

Calcium channel blocker (CCB) overdose is often lethal. Conventional medical treatment includes i.v. calcium, high doses of catecholamines, insulin, and glucagon. A new inotropic drug, levosimendan, should be considered in severe CCB poisoning. Levosimendan's pharmacologic features differ from other inotropic drugs. It is a calcium sensitizer and improves contraction without increasing intracytosolic calcium concentration. We describe two patients with serious CCB overdose. Despite intensive medical and mechanical cardiovascular support, both patients remained in shock. Hemodynamics gradually improved after administration of levosimendan.

摘要

钙通道阻滞剂(CCB)过量通常是致命的。传统的医学治疗包括静脉注射钙剂、高剂量的儿茶酚胺、胰岛素和胰高血糖素。对于严重的CCB中毒,应考虑使用一种新型的正性肌力药物——左西孟旦。左西孟旦的药理特性与其他正性肌力药物不同。它是一种钙增敏剂,可在不增加细胞内钙浓度的情况下改善心肌收缩。我们描述了两名严重CCB过量的患者。尽管给予了积极的药物和机械性心血管支持,但两名患者仍处于休克状态。给予左西孟旦后,血流动力学逐渐改善。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验